Rhythm Pharmaceuticals Inc (RYTM)
64.42
-1.16
(-1.77%)
USD |
NASDAQ |
Nov 12, 15:13
Rhythm Pharmaceuticals Revenue (Annual): 77.43M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 77.43M |
December 31, 2022 | 23.64M |
Date | Value |
---|---|
December 31, 2021 | 3.154M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
3.154M
Minimum
2021
77.43M
Maximum
2023
34.74M
Average
23.64M
Median
2022
Revenue (Annual) Benchmarks
Eli Lilly and Co | 34.12B |
TG Therapeutics Inc | 233.66M |
Regeneron Pharmaceuticals Inc | 13.12B |
Voyager Therapeutics Inc | 250.01M |
Mirum Pharmaceuticals Inc | 186.37M |